Procalcitonin as a marker of severity in septic shock

Langenbeck's Archives of Surgery

Volumn 384, Issue 1, 1999, Pages 33-38

  Schroder J ^a   Staubach, K H ^b   Zabel, P ^c   Stuber F ^d   Kremer, B ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c RESEARCH CENTER BORSTEL   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

C reactive protein; Cytokines; Procalcitonin; Sepsis; Septic shock

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 6; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; INFECTIOUS COMPLICATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; SURGICAL PATIENT;

APACHE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PANCREATITIS; PERITONITIS; PROGNOSIS; PROTEIN PRECURSORS; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0345034611     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004230050170     Document Type: Article

References (27)

1. Aarden LA, de Groot ER, Schaap OL, Lansdorp PM (1987) Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416
2. Al-Nawas B, Shah PM (1996) Procalcitonin in patients with and without immuno-suppression and sepsis. Infection 24:434-436
3. Al-Nawas B, Krammer I, Shah PM (1995) Procalcitonin in the diagnosis of severe infections. Eur J Med Res 1:331-333
4. Assicot M, Gendrel D, Carsin, H. Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518
5. De Werra I, Jaccard C, Corradin SB. Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner JD, Glauser MP, Heumann D (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparions in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25:607-613
6. Biffl WL, Moore EE, Moore FA, Peterson VM (1996) Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation. Ann Surg 224:647-664
7. Bone RC (1994) Sepsis and its complications: the clinical problem. Crit Care Med 22:S8-S11
8. Bone RC (1996) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24:163-172
9. Bone RC, Sprung CL, Sibbald WJ (1992) Definitions for sepsis and orgar failure. Crit Care Med 20:724-726
10. Casey LC, Balk RA, Bone RC (1993) Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 119:771-778
11. Damas P, Ledoux D, Nys M, Vrindts Y, de Groote D, Franchimont P, Lamy M (1992) Cytokine serum level during severe sepsis in human: IL-6 as a marker of severity. Ann Surg 215:356-362
12. Dandona P, Nix D, Wilson M, Aljada A, Love J, Assicot M, Bohuon C (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79:1605-1608
13. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens GH, Strack van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA (1989). Increased plasma levels of interleukin-6 in sepsis. Blood 74:1704-1710
14. Ertel W, Morrison, MH, Wang P, Ba ZF, Ayala A, Chaudry IH (1991) The complex pattern of cytokines in sepsis. Association between prostaglandins, cachectin and interleukins. Ann Surg 214:141-148
15. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW (1995) Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347
16. Espevik T, Nissen-Meyer J (1986) A highly sensitive cell line, WEHI 164 subclone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105
17. Fong Y, Lowry SF (1990) Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 55:157-170
18. Fona Y, Moldawer L, Morano M, Wie H, Tatter SB, Clarick RH, Santhanam U, Sherris D, May LT, Sehgal PB, Lowry SF (1989) Endotoxemia elecits increased circulating β2-Ifn/IL-6 in man. J Immunol 142:2321-2324
19. Fong Y, Moldawer LL, Shires GT, Lowry SF (1990) The biological characteristics of cytokines and their implication in surgical injury. Surg Gynecol Obstet 170:363-378
20. Goris RJA, te Broekhorst TPA, Nuytinck JKS, Gimbere JSF (1985) Multiple-organ failure-generalized autodestructive inflammation? Arch Surg 120:1109-1115
21. Gramm HJ (1996) A new marker for the activity of the inflammatory host response in severe infections. Intensive Care Med 7[Suppl 1]:37
22. Knaus WA, Draper EA, Wagner DP, Zimmermann JE (1985) Apache II: a severity of disease classification system. Crit Care Med 13:818-829
23. Liao J, Keiser JA, Scales WE, Kunkel SL, Kluger MJ (1995) Role of epinephrine in TNF and IL-6 production from isolated perfused rat liver. Am J Physiol 268:R896-R901
24. Michie HR, Manogue KR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM, Wilmore DW (1988) Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486
25. Riché F, Panis Y, Laisné MJ, Briard C, Cholley B, Bernard-Poenaru O, Graulet AM, Gueris J, Valleur P (1996) High tumor necrosis factor serum level is associated with increased survival in patients with abdominal septic shock: a prospective study in 59 patients. Surgery 120:801-807
26. Stüber F, Schade FU, Schröder J, Bokelmann F, Petersen M, Seifert J (1997) Acute-phase proteins in SIRS. In: Faist E, Baue A, Schildberg FW (eds) MOF, MODS and SIRS - concepts, clinical correlates and therapy. Pabst Science Publishers, Berlin, pp 183-186
27. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF (1992) TNF soluble receptors protect circulate during experimental and clinical inflammation and can against excessive TNF alpha in vitro and in vivo. Proc Natl Acad Sci USA 89:4845-4849